Company Profile

Nanoscope Technologies LLC
Profile last edited on: 11/12/2019      CAGE: 5KA02      UEI: H6DNZXT5MMT1

Business Identifier: Technologies used by pathologists to diagnose diseases
Year Founded
2009
First Award
2015
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1312 Brown Trail
Bedford, TX 76022
   (817) 719-2692
   info@nanoscopetech.com
   www.nanoscopetech.com
Location: Single
Congr. District: 24
County: Tarrant

Public Profile

Organized around development of new methods and devices for scientific, industrial and biomedical applications, Nanoscope has developed a range of biomedical technologies which include diagnostics and therapeutic devices and molecules. The firm has also developed various biomedical technologies to include diagnostics and therapeutic devices and molecules. With capabilities in microscopic imaging and spectroscopy based pathological analysis of cancer and diseases with non-neoplastic changes. Early detection of diseases (via rigorous analysis) can greatly increase the chances for successful and recurrence-free treatment. NanoScope Technologies has developed multimodal pathological microscope that enables simultaneous characterization of nano-architecture of selected cells while visualizing and imaging of morphological features by pathologists. This economical and fully automated system will aid label-free detection of early neoplastic as well as non-neoplastic changes that occur in various human and animal diseases. The firm is working on Multi-Characteristic Opsin for efficient light activation. Optogenetics has revolutionized basic biomedical research and is expected to have therapeutic impact in near future. Current electrode based stimulation methods are invasive, non-specific, and have limited resolution. NanoScope Technologies has developed a suite of synthetic Multi-Characteristics Opsins having high light sensitivity for sensitizing variety of cells/tissues towards light so that the targeted cells can be optically activated using very low intense light. Besides basic research, the therapeutic potential includes vision restoration and other physiological disorders. Also working on NanoSpectro device for painless in-situ cancer diagnosiss, NanoScope Technologies has developed novel, non-invasive patent pending Cancer Diagnostic Device as a low powered, safe bright light device that can detect and differentiate cancer tissue from normal tissue and benign tumor.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
15-19
Revenue Range
1.5M-2M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Sulagna Bhattacharya -- CEO and COO

  Beamon Agarwal -- Clinical Coordinator

  Adnan Dibas

  Samarendra Mohanty -- Founder and Chief Scientific/Technology Officer

  Sanjay Pradhan -- Senior Scientist

  Hrebesh M Subhash -- Senior Technology Officer

  Weldon Wright -- CMO

Company News

There are no news available.